Scientific article

Thérapie assistée par psychédéliques en médecine palliative

Published inRevue médicale suisse, vol. 19, no. 855, p. 2395-2398
Publication date2023

Depression, anxiety and existential distress associated with terminal illness have a major impact on quality of life among palliative care patients. Psychedelics are emerging as catalysts for reflective, introspective and sometimes spiritual exploration as part of psychotherapy, with potentially rapid and long-lasting multiple beneficial effects. Psychedelic-assisted psychotherapy (PAP) combines preparation, substance intake, and integration of experiences to facilitate profound psychospiritual change. Despite methodological and administrative hurdles, interest in this innovative approach continues to grow because of its potential to offer remission where conventional approaches have shown little benefits.

  • Anxiety
  • Hallucinogens
  • Humans
  • Palliative Medicine
  • Psychotherapy
  • Quality of Life
Citation (ISO format)
SCHALLER, Amandine et al. Thérapie assistée par psychédéliques en médecine palliative. In: Revue médicale suisse, 2023, vol. 19, n° 855, p. 2395–2398. doi: 10.53738/REVMED.2023.19.855.2395
Main files (1)
Article (Published version)
accessLevelRestrictedaccessLevelPublic 07/01/2025
ISSN of the journal1660-9379

Technical informations

Creation05/28/2024 1:48:14 PM
First validation06/04/2024 9:27:22 AM
Update time06/04/2024 9:27:22 AM
Status update06/04/2024 9:27:22 AM
Last indexation06/04/2024 9:27:43 AM
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack